Abstract
The effects of immune complex infusion on the clearance of antibody (R3/13)-coated and NEM-treated rat erythrocytes by the splenic component of the rat mononuclear phagocyte system (MPS) were investigated. Equivalence complexes of BSA-anti-BSA produced a significant delay in the clearance of the NEM cells (pre-infusion T1/2 19.7 +/- 3.9 min, post-infusion T1/2 26.5 +/- 3.8 min, mean +/- SE, n = 6, P less than 0.01), but this effect could be abolished by agents that prevented the changes in the splenic blood flow that followed complement activation. The immune complexes formed in 10-fold antigen excess (mean size 15S) did not delay the clearance of the NEM cells. Clearance of R3/13-coated cells was impaired by the infusion of immune complexes prepared at equivalence. 10-fold antigen excess or complexes prepared with F(ab')2 fragments of rabbit anti-BSA antibody. The inhibition of red cell clearance was independent of changes in blood flow, but the degree of inhibition produced did not correlate well with the dose of immune complex injected.
Full text
PDF![81](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fae9/1453147/e014dcfbaf02/immunology00174-0077.png)
![82](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fae9/1453147/11e641e1bfb3/immunology00174-0078.png)
![83](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fae9/1453147/44c965c141b1/immunology00174-0079.png)
![84](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fae9/1453147/685315c06c06/immunology00174-0080.png)
![85](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fae9/1453147/0907889d9fdf/immunology00174-0081.png)
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Berger M., Gaither T. A., Hammer C. H., Frank M. M. Lack of binding of human C3, in its native state, to C3b receptors. J Immunol. 1981 Oct;127(4):1329–1334. [PubMed] [Google Scholar]
- Cochrane C. G., Koffler D. Immune complex disease in experimental animals and man. Adv Immunol. 1973;16(0):185–264. doi: 10.1016/s0065-2776(08)60298-9. [DOI] [PubMed] [Google Scholar]
- Eden A., Bianco C., Nussenzweig V., Mayer M. M. C3 split products inhibit the binding of antigen-antibody-complement complexes to B lymphocytes. J Immunol. 1973 May;110(5):1452–1453. [PubMed] [Google Scholar]
- Fraker P. J., Speck J. C., Jr Protein and cell membrane iodinations with a sparingly soluble chloroamide, 1,3,4,6-tetrachloro-3a,6a-diphrenylglycoluril. Biochem Biophys Res Commun. 1978 Feb 28;80(4):849–857. doi: 10.1016/0006-291x(78)91322-0. [DOI] [PubMed] [Google Scholar]
- Laurell C. B. Quantitative estimation of proteins by electrophoresis in agarose gel containing antibodies. Anal Biochem. 1966 Apr;15(1):45–52. doi: 10.1016/0003-2697(66)90246-6. [DOI] [PubMed] [Google Scholar]
- Lawrence S., Lockwood C. M., Peters D. K. Studies on NEM-treated erythrocyte clearance in the rabbit, with special reference to the effects of circulating immune complexes. Clin Exp Immunol. 1981 May;44(2):433–439. [PMC free article] [PubMed] [Google Scholar]
- Reid K. B. Complement fixation by the F(ab')2-fragment of pepsin-treated rabbit antibody. Immunology. 1971 May;20(5):649–658. [PMC free article] [PubMed] [Google Scholar]
- Theofilopoulos A. N., Wilson C. B., Bokisch V. A., Dixon F. J. Binding of soluble immune complexes to human lymphoblastoid cells. II. Use of Raji cells to detect circulating immune complexes in animal and human sera. J Exp Med. 1974 Nov 1;140(5):1230–1244. doi: 10.1084/jem.140.5.1230. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Williams B. D., Pussell B. A., Lockwood C. M., Cotton C. Defective reticuloendothelial system function in rheumatoid arthritis. Lancet. 1979 Jun 23;1(8130):1311–1314. doi: 10.1016/s0140-6736(79)91947-0. [DOI] [PubMed] [Google Scholar]